Phalanx® Spray 20mg/ml Mibe Pharma 60ml

Phalanx® Spray 20mg / ml Mibe Pharma

Phalanx 20 mg / ml is indicated for the treatment of androgenetic alopecia in men and women.

Dosage

Dosage
Apply 1 ml of Phalanx 20 mg / ml twice a day (in the morning and in the evening) to the affected areas of the scalp.
The amount applied daily, i.e. 2 x 1 ml of solution, should not be exceeded, regardless of the size of the affected scalp area.
Pediatric population under the age of 18 and patients aged 65 and over
Phalanx 20 mg / ml should not be used in these patient groups as efficacy and safety results from controlled studies in these age groups are not available.
Special populations
There are no specific recommendations for use in patients with renal or hepatic impairment.

Method of administration

Cutaneous use.
Phalanx 20 mg / ml is for external use on dry scalp. The instructions for use should be followed carefully and applying the medicine to other parts of the body besides the scalp is contraindicated.
Wash hands thoroughly after applying Phalanx 20 mg / ml, to avoid accidental contact with mucous membranes and eyes.
After applying Phalanx 20 mg / ml, the hair should be styled as usual. However, the scalp should not be wet for about 4 hours. This will prevent Phalanx 20 mg / ml from being washed off.
Each pack of Phalanx 20 mg / ml contains 2 different pump spray applicators:

A pre-assembled applicator for application over a large area
A separate applicator with an extendable end for smaller areas

Both applicators can be exchanged by detaching one applicator and replacing it with the other.
For a 1 ml dose, 6 puffs of the spray are required.
Instructions for use / application
The solution is sprayed directly on the scalp in the area of hair loss. To do this, press the pump 6 times. After each application, the liquid should be distributed over the affected area with the fingertips, thus avoiding inhalation of the nebulization.

Duration of use

The onset and extent of hair growth differ in individual patients.
Generally, treatment done twice a day for 2-4 months is required before you can see an effect. To maintain the effect, it is recommended to continue with 2 applications per day, without interruption. Better results will not be obtained by applying larger amounts of Phalanx 20 mg / ml or by applying it more frequently. Regarding the possible therapeutic effect, there is sufficient clinical experience for a treatment period of up to 48 weeks.
If the desired therapeutic response is not achieved within 8 months, the treatment should be discontinued.
In some patients, a temporary increase in hair loss has been observed 2 to 6 weeks after starting treatment. This effect is due to the fact that the resting phase (telogen phase) of the hair growth cycle is shorter in hair follicles treated with minoxidil and the growth phase (anagen phase) is reached more quickly. This stimulates the growth of new hair which causes the “old”, no longer active ones to fall out of the scalp. This creates the initial impression of hair loss. However, this event is accompanied by increased hair regrowth. This effect subsides within a few weeks and can be interpreted as the first sign of the effect of minoxidil.

Too low dosage

If too little Phalanx 20 mg / ml is applied or a dose is missed, the user does not need to make up for the missed dose. In this case, treatment should be continued with the recommended dose.
It is necessary to continue the treatment to improve and maintain hair growth. Otherwise, hair loss may occur again

Contraindications

Phalanx 20 mg / ml should not be used in the following cases:

hypersensitivity to the active substance or to any of the excipients listed in section 6.1.,
concomitant use of occlusive dressing or other medical preparations for topical use on the scalp,
sudden or irregular hair loss,
in pregnant or breastfeeding women,
in users with any scalp abnormality (including psoriasis, sunburn, shaved scalp or if the scalp is affected by burns or scars).

Special warnings and precautions for use

Before starting treatment with Phalanx 20 mg / ml, the patient should be thoroughly examined and his medical history requested. The patient must have a scalp ...

Format

60ml spray bottle